At the time of writing, Lucid Diagnostics Inc [LUCD] stock is trading at $1.07, saw in change for the day. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The LUCD shares have gain 4.90% over the last week, with a monthly amount glided 4.90%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Lucid Diagnostics Inc [NASDAQ: LUCD] stock has seen the most recent analyst activity on December 27, 2021, when Ascendiant Capital Markets initiated its Buy rating and assigned the stock a price target of $16. Previously, Needham started tracking the stock with Buy rating on November 08, 2021, and set its price target to $17. On November 08, 2021, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $21 on the stock. BTIG Research started tracking the stock assigning a Buy rating and suggested a price target of $14 on November 08, 2021.
For the past year, the stock price of Lucid Diagnostics Inc fluctuated between $0.73 and $1.80. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. Lucid Diagnostics Inc [NASDAQ: LUCD] shares were valued at $1.07 at the most recent close of the market. An investor can expect a potential return of 86.92% based on the average LUCD price forecast.
Analyzing the LUCD fundamentals
According to Lucid Diagnostics Inc [NASDAQ:LUCD], the company’s sales were 4.36M for trailing twelve months, which represents an 19.16% jump. Gross Profit Margin for this corporation currently stands at -0.34% with Operating Profit Margin at -9.79%, Pretax Profit Margin comes in at -3.85%, and Net Profit Margin reading is -6.81%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -4.04 and Total Capital is -1.24. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.5.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Lucid Diagnostics Inc [NASDAQ:LUCD] has a current ratio of 1.15. In addition, the Quick Ratio stands at 1.12 and the Cash Ratio stands at 1.06. Considering the valuation of this stock, the price to sales ratio is 33.68.
Transactions by insiders
Recent insider trading involved Matheis Dennis, Director, that happened on Aug 20 ’25 when 100000.0 shares were purchased. Director, Matheis Dennis completed a deal on May 20 ’25 to buy 0.19 million shares. Meanwhile, Director Matheis Dennis bought 0.13 million shares on May 21 ’25.
